Enhancing soluble expression and purification of a bispecific scFv antibody in <i>Escherichia coli</i> using chaperones. [PDF]
Alidousti-Shahraki Z +3 more
europepmc +1 more source
Engineering, Expression, Purification, and Application of Glycosaminoglycan-Specific Antibodies. [PDF]
Duraivelan K +7 more
europepmc +1 more source
Development and Evaluation of "a PEGylated Anti-Tau ScFv for SPECT Imaging" in a Rat Model of Traumatic Brain Injury. [PDF]
Sajjadi E +5 more
europepmc +1 more source
Fc-free single-chain antibody mRNA therapy for airway infection of multidrug-resistant Pseudomonas aeruginosa. [PDF]
Kinoshita M +8 more
europepmc +1 more source
Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants. [PDF]
Hsu CH +6 more
europepmc +1 more source
Targeted cellular micropharmacies deliver therapeutic agents to the brain. [PDF]
Malviya M +10 more
europepmc +1 more source
The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy. [PDF]
Wenzel EV +17 more
europepmc +1 more source
Efficacy of anti-VEGF single-chain variable fragment AAV-based gene therapy in a laser-induced choroidal neovascularisation mouse model. [PDF]
Salman A +12 more
europepmc +1 more source
Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice. [PDF]
Klein SG +12 more
europepmc +1 more source
ScFv T1 Protects Against Mitochondrial Damage of SH-SY5Y Cells Caused by Extracellular Tau Aggregates. [PDF]
Wang Z +5 more
europepmc +1 more source

